Your browser doesn't support javascript.
loading
Hybrid extracellular vesicles-liposome incorporated advanced bioink to deliver microRNA.
Elkhoury, Kamil; Chen, Mo; Koçak, Polen; Enciso-Martínez, Eduardo; Bassous, Nicole Joy; Lee, Myung Chul; Byambaa, Batzaya; Rezaei, Zahra; Li, Yang; Ubina López, María Elizabeth; Gurian, Melvin; Sobahi, Nebras; Hussain, Mohammad Asif; Sanchez-Gonzalez, Laura; Leijten, Jeroen; Hassan, Shabir; Arab-Tehrany, Elmira; Ward, Jennifer Ellis; Shin, Su Ryon.
Afiliação
  • Elkhoury K; Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Cambridge, MA 02139, United States of America.
  • Chen M; LIBio, Université de Lorraine, F-54000 Nancy, France.
  • Koçak P; Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Cambridge, MA 02139, United States of America.
  • Enciso-Martínez E; Department of Gynecology, Obstetrics & Gynecology Hospital, Fudan University, Shanghai 200011, People's Republic of China.
  • Bassous NJ; Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Cambridge, MA 02139, United States of America.
  • Lee MC; Department of Biomedical Engineering, Faculty of Engineering, Istinye University, 34396 Sariyer/Istanbul, Trukey.
  • Byambaa B; Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Cambridge, MA 02139, United States of America.
  • Rezaei Z; Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Cambridge, MA 02139, United States of America.
  • Li Y; Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Cambridge, MA 02139, United States of America.
  • Ubina López ME; 3D BioLabs, LLC, 700 Main St., Cambridge, MA 02138, United States of America.
  • Gurian M; Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Cambridge, MA 02139, United States of America.
  • Sobahi N; Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Cambridge, MA 02139, United States of America.
  • Hussain MA; Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Cambridge, MA 02139, United States of America.
  • Sanchez-Gonzalez L; Department of Developmental BioEngineering, University of Twente, Enschede, Overijssel 7522 NB, The Netherlands.
  • Leijten J; Department of Electrical and Computer Engineering, King Abdulaziz University, Jeddah 21569, Saudi Arabia.
  • Hassan S; Department of Electrical and Computer Engineering, King Abdulaziz University, Jeddah 21569, Saudi Arabia.
  • Arab-Tehrany E; LIBio, Université de Lorraine, F-54000 Nancy, France.
  • Ward JE; Department of Developmental BioEngineering, University of Twente, Enschede, Overijssel 7522 NB, The Netherlands.
  • Shin SR; Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Cambridge, MA 02139, United States of America.
Biofabrication ; 14(4)2022 08 19.
Article em En | MEDLINE | ID: mdl-35917808
ABSTRACT
In additive manufacturing, bioink formulations govern strategies to engineer 3D living tissues that mimic the complex architectures and functions of native tissues for successful tissue regeneration. Conventional 3D-printed tissues are limited in their ability to alter the fate of laden cells. Specifically, the efficient delivery of gene expression regulators (i.e. microRNAs (miRNAs)) to cells in bioprinted tissues has remained largely elusive. In this study, we explored the inclusion of extracellular vesicles (EVs), naturally occurring nanovesicles (NVs), into bioinks to resolve this challenge. EVs show excellent biocompatibility, rapid endocytosis, and low immunogenicity, which lead to the efficient delivery of miRNAs without measurable cytotoxicity. EVs were fused with liposomes to prolong and control their release by altering their physical interaction with the bioink. Hybrid EVs-liposome (hEL) NVs were embedded in gelatin-based hydrogels to create bioinks that could efficiently encapsulate and deliver miRNAs at the target site in a controlled and sustained manner. The regulation of cells' gene expression in a 3D bioprinted matrix was achieved using the hELs-laden bioink as a precursor for excellent shape fidelity and high cell viability constructs. Novel regulatory factors-loaded bioinks will expedite the translation of new bioprinting applications in the tissue engineering field.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Bioimpressão / Vesículas Extracelulares Idioma: En Revista: Biofabrication Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Bioimpressão / Vesículas Extracelulares Idioma: En Revista: Biofabrication Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos